PILOT TRIAL OF AN ADJUVANT PENTAVALENT VACCINE FOR PATIENTS WITH SMALL CELL LUNG CANCER (SCLC)

被引：0
|
作者：
Krug, Lee M. [1 ]
Varghese, Anna [1 ]
Ragupathi, Govind [2 ]
George, Constantine [2 ]
Sawada, Ritsuko [3 ]
Scholz, Wolfgang W. [3 ]
Hansen, David [3 ]
Livingston, Philip O. [3 ]
Delasos, Lukas [1 ]
Pietanza, Maria C. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, Dept Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Mabvax Therapeut, San Diego, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
small cell lung cancer; vaccine; immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.13-007
引用
收藏
页码：S1231 / S1232
页数：2
相关论文
共 50 条
  • [31] A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC).
    Nogami, N.
    Kiura, K.
    Takigawa, N.
    Harita, S.
    Chikamori, K.
    Shibayama, T.
    Tabata, M.
    Hotta, K.
    Shinkai, T.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] A randomised pilot study of SRL172 (Mycobacterium vaccae) in patients with small cell lung cancer (SCLC) treated with chemotherapy
    Assersohn, L
    Souberbielle, BE
    Spencer, L
    Bass, R
    Mendes, R
    Smith, IE
    O'Brien, MER
    BRITISH JOURNAL OF CANCER, 2000, 83 : 43 - 43
  • [33] Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
    Park, Cheol-Kyu
    Oh, In-Jae
    Kim, Young-Chul
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (02) : 346 - 349
  • [34] A randomized pilot study of SRL172 (Mycobacterium vaccae) in patients with small cell lung cancer (SCLC) treated with chemotherapy
    Assersohn, L
    Souberbielle, BE
    O'Brien, MER
    Archer, CD
    Mendes, R
    Bass, R
    Bromelow, KV
    Palmer, RD
    Bouilloux, E
    Kennard, DA
    Smith, IE
    CLINICAL ONCOLOGY, 2002, 14 (01) : 23 - 27
  • [35] A combination chemotherapy of carboplatin and irinotecan in elderly patients with small cell lung cancer (SCLC).
    Okamoto, H
    Kudoh, H
    Nagatomo, A
    Kunikane, H
    Watanabe, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 669S - 669S
  • [36] Outcome for patients with small cell lung cancer (SCLC) in Mid-Western Ireland
    Quintyne, K. I.
    O'Leary, N.
    Sabu, C. B.
    Gupta, R. K.
    LUNG CANCER, 2009, 63 : S10 - S11
  • [37] Why do some patients with small cell lung cancer (SCLC) not get chemotherapy?
    Mackean, M.
    Allen, A.
    Price, A.
    Ironside, J.
    Erridge, S.
    Campbell, S.
    Patrizio, A.
    Fergusson, R.
    LUNG CANCER, 2012, 75 : S59 - S59
  • [38] ORAL IFOSFAMIDE AND ETOPOSIDE FOR SMALL-CELL LUNG-CANCER (SCLC) PATIENTS
    CERNY, T
    THATCHER, N
    LIND, M
    CARROLL, K
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S101 - S101
  • [39] Epirubicin combined with ifosfamide in relapsed or refractory small cell lung cancer (SCLC) patients
    Jacot, William
    Molinier, Olivier
    Colinet, Benoit
    Bozonnat, Marie-Cecile
    Quantin, Xavier
    Gervais, Radj
    Pujol, Jean-Louis
    ANNALS OF ONCOLOGY, 2006, 17 : 232 - 233
  • [40] New aspects in the treatment of small cell lung cancer (SCLC)
    Marx, GM
    Galani, E
    Harper, P
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 13 - 13
12345